Editas Medicine Inc (EDIT)
5.62
+0.16
(+3.02%)
USD |
NASDAQ |
May 02, 16:00
5.63
+0.01
(+0.18%)
After-Hours: 17:01
Editas Medicine Accounts Payable (Quarterly): 8.269M for Dec. 31, 2023
Accounts Payable (Quarterly) Chart
Historical Accounts Payable (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 8.269M |
September 30, 2023 | 10.41M |
June 30, 2023 | 8.066M |
March 31, 2023 | 9.047M |
December 31, 2022 | 9.511M |
September 30, 2022 | 6.836M |
June 30, 2022 | 6.169M |
March 31, 2022 | 4.693M |
December 31, 2021 | 5.05M |
September 30, 2021 | 3.402M |
June 30, 2021 | 4.415M |
March 31, 2021 | 8.91M |
December 31, 2020 | 6.408M |
September 30, 2020 | 5.158M |
June 30, 2020 | 6.339M |
March 31, 2020 | 10.39M |
December 31, 2019 | 5.843M |
September 30, 2019 | 6.624M |
Date | Value |
---|---|
June 30, 2019 | 3.981M |
March 31, 2019 | 6.557M |
December 31, 2018 | 5.327M |
September 30, 2018 | 5.04M |
June 30, 2018 | 4.661M |
March 31, 2018 | 8.996M |
December 31, 2017 | 4.02M |
September 30, 2017 | 6.976M |
June 30, 2017 | 8.156M |
March 31, 2017 | 15.23M |
December 31, 2016 | 4.64M |
September 30, 2016 | 3.718M |
June 30, 2016 | 5.844M |
March 31, 2016 | 2.909M |
December 31, 2015 | 1.381M |
September 30, 2015 | 1.515M |
December 31, 2014 | 2.595M |
Accounts Payable Definition
Accounting terminology for money that a company owes to vendors for services or products that it purchased on credit. Accounts payable appear on the balance sheet as a current liability.
Accounts Payable (Quarterly) Range, Past 5 Years
3.402M
Minimum
Sep 2021
10.41M
Maximum
Sep 2023
6.817M
Average
6.408M
Median
Dec 2020
Accounts Payable (Quarterly) Benchmarks
Vertex Pharmaceuticals Inc | 364.90M |
Moderna Inc | 520.00M |
Amicus Therapeutics Inc | 15.12M |
Geron Corp | 6.161M |
Regeneron Pharmaceuticals Inc | 606.60M |